Research Material
This working group is focused to promote the identification/standardization of core outcomes set (COS) projects for clinical drug development in CNS therapeutic areas. Therefore, once identified good practices, next step is to promote its application by sponsors during the process of clinical trials design. Overall the idea is to promote good practices on the decision for COAs Selection in early clinical trials.
